The estimates show wolf numbers peak in May due to new pups being born, but the numbers start to decline afterwards due to ...

The move follows strong industry data pointing to robust cruise demand and pricing trends holding firm through the second ...

Chris Senyek, Wolfe Research chief investment strategist, joins CNBC's 'Squawk on the Street' to discuss market outlooks, ...

Former Deputy Treasury Secretary Roger Altman said he did not think Jerome Powell would agree to leave if the president asked ...

Stocks rebounded on Wednesday after President Donald Trump denied reports that he was close to ousting Powell as chairman of ...

Johnson & Johnson (NYSE:JNJ) is one of Goldman Sachs’ top healthcare stock picks. On July 10, analysts at Wolfe Research ...

Fintel reports that on July 15, 2025, Wolfe Research downgraded their outlook for Realty Income (NYSE:O) from Outperform to ...

Investing.com - Wolfe Research initiated coverage on Chime Financial (NASDAQ:CHYM) on Monday with an Outperform rating and a $38.00 year-end 2025 price target. According to InvestingPro data, this ...

Overall, Wolfe favors a mix of growth and value as the second half of 2025 begins. Related articles Wolfe Research refreshes high-conviction ideas heading into H2 ...

BridgeBio Pharma, Inc. (NASDAQ:BBIO) is one of the 10 biotech stocks screaming a buy. On June 17, Wolfe Research initiated coverage of the stock with an ‘Outperform’ rating and a $49 price ...

Fintel reports that on May 13, 2025, Wolfe Research upgraded their outlook for Insulet (BMV:PODD) from Peer Perform to Outperform.

Fastenal (NASDAQ:FAST) on Thursday was upgraded to Peer Perform from a previous investment rating of Underperform by analysts at Wolfe Research. They said the industrial distributor appears well ...